| Year |
Citation |
Score |
| 2009 |
Gonzalez‐Muniz R, Cornille F, Bergeron F, Ficheux D, Pothier J, Durieux C, Roques BP. Solid phase synthesis of a fully active analogue of cholecystokinin using the acid-stable Boc-Phe (p-CH2) SO3H as a substitute for Boc-Tyr(SO3H) in CCK8. International Journal of Peptide and Protein Research. 37: 331-340. PMID 1894448 DOI: 10.1111/J.1399-3011.1991.Tb00747.X |
0.374 |
|
| 2009 |
Mccort‐Tranchepain I, Ficheux D, Durieux C, Roques BP. Replacement of Tyr-SO3H by a p-carboxymethyl-phenylalanine in a CCK8-derivative preserves its high affinity for CCK-B receptor. International Journal of Peptide and Protein Research. 39: 48-57. PMID 1378822 DOI: 10.1111/J.1399-3011.1992.Tb01555.X |
0.518 |
|
| 2002 |
Léna I, Roques BP, Durieux C. Dual Modulation of Dopamine Release from Anterior Nucleus Accumbens Through Cholecystokinin‐B Receptor Subsites Journal of Neurochemistry. 68: 162-168. PMID 8978722 DOI: 10.1046/J.1471-4159.1997.68010162.X |
0.435 |
|
| 2002 |
Blanco-Príeto MJ, Durieux C, Daugé V, Fattal E, Couvreur P, Roques BP. Slow delivery of the selective cholecystokinin agonist pBC 264 into the rat nucleus accumbens using microspheres. Journal of Neurochemistry. 67: 2417-2424. PMID 8931474 DOI: 10.1046/J.1471-4159.1996.67062417.X |
0.423 |
|
| 1997 |
Blommaert AGS, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor. Journal of Medicinal Chemistry. 40: 647-658. PMID 9057851 DOI: 10.1021/Jm9603072 |
0.627 |
|
| 1996 |
Migaud M, Durieux C, Viereck J, Soroca-Lucas E, Fournié-Zaluski M, Roques BP. The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A. Peptides. 17: 601-607. PMID 8804068 DOI: 10.1016/0196-9781(96)00036-8 |
0.485 |
|
| 1995 |
Migaud M, Roques BP, Durieux C. Evidence for a high-affinity uptake system for cholecystokinin octapeptide (CCK8) in rat cortical synaptosomes. European Journal of Neuroscience. 7: 1074-1079. PMID 7613612 DOI: 10.1111/J.1460-9568.1995.Tb01094.X |
0.503 |
|
| 1994 |
Durieux C, Derrien M, Maldonado R, Valverde O, Blommaert A, Fournié‐Zaluski M‐, Roques BP. CCK-B antagonists exhibit antidepressant-like effects and potentiate endogenous enkephalin analgesia. Correlation with in vivo binding affinities and brain penetration. Annals of the New York Academy of Sciences. 713: 355-357. PMID 8185186 DOI: 10.1111/J.1749-6632.1994.Tb44091.X |
0.492 |
|
| 1994 |
Derrien M, Durieux C, Roques BP. Antidepressant‐like effects of CCKB antagonists in mice: antagonism by naltrindole British Journal of Pharmacology. 111: 956-960. PMID 8019773 DOI: 10.1111/J.1476-5381.1994.Tb14832.X |
0.335 |
|
| 1994 |
Migaud M, Roques BP, Durieux C. Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices. Neuropharmacology. 33: 737-743. PMID 7936111 DOI: 10.1016/0028-3908(94)90113-9 |
0.446 |
|
| 1994 |
Derrien M, McCort-Tranchepain I, Ducos B, Roques BP, Durieux C. Heterogeneity of CCK-B receptors involved in animal models of anxiety. Pharmacology, Biochemistry and Behavior. 49: 133-141. PMID 7816864 DOI: 10.1016/0091-3057(94)90467-7 |
0.473 |
|
| 1994 |
Ladurelle N, Durieux C, Roques BP, Daugé V. Different modifications of the dopamine metabolism in the core and shell parts of the nucleus accumbens following CCK-A receptor stimulation in the shell region. Neuroscience Letters. 178: 5-10. PMID 7816338 DOI: 10.1016/0304-3940(94)90276-3 |
0.324 |
|
| 1994 |
Bertrand P, Böhme GA, Durieux C, Guyon C, Capet M, Jeantaud B, Boudeau P, Ducos B, Pendley CE, Martin GE, Floch A, Doble A. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists European Journal of Pharmacology. 262: 233-245. PMID 7813588 DOI: 10.1016/0014-2999(94)90737-4 |
0.566 |
|
| 1993 |
Corringer PJ, Weng JH, Ducos B, Durieux C, Boudeau P, Bohme A, Roques BP. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives. Journal of Medicinal Chemistry. 36: 166-172. PMID 8421283 DOI: 10.1021/Jm00053A022 |
0.547 |
|
| 1993 |
Derrien M, Durieux C, Dauge V, Roques BP. Involvement of D2 dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus accumbens Brain Research. 617: 181-188. PMID 8402145 DOI: 10.1016/0006-8993(93)91084-6 |
0.377 |
|
| 1993 |
Roques BP, Corringer P, Derrien M, Daugé V, Durieux C. Structure-based design and pharmacological properties of potent selective and systemically active CCK-B peptidomimetics Bioorganic & Medicinal Chemistry Letters. 3: 847-850. DOI: 10.1016/S0960-894X(00)80678-2 |
0.484 |
|
| 1992 |
Ruiz‐Gayo M, Durieux C, Fournié‐Zaluski MC, Roques BP. Stimulation of δ‐Opioid Receptors Reduces the In Vivo Binding of the Cholecystokinin (CCK)‐B‐Selective Agonist [3H]pBC 264: Evidence for a Physiological Regulation of CCKergic Systems by Endogenous Enkephalins Journal of Neurochemistry. 59: 1805-1811. PMID 1357099 DOI: 10.1111/J.1471-4159.1992.Tb11013.X |
0.522 |
|
| 1992 |
Durieux C, Ducos B, Ruiz-Gayo M, Corringer PJ, Roques BP. Evidence for B-type cholecystokinin receptor heterogeneity in rodent brain Neuropeptides. 22: 20. DOI: 10.1016/0143-4179(92)90388-D |
0.423 |
|
| 1992 |
Corringer PJ, Durieux C, Ruiz‐Gayo M, Roques BP. Tritium labelling of two highly selective agonists for CCK‐B receptor: [3H]propionyl‐Tyr(SO3Na)‐gNle‐mGly‐Trp‐(N‐Me)Nle‐Asp‐Phe‐NH2([3H]pBC 264) [3H]propionyl‐γDLys‐Trp‐Nle‐Asp‐Phe‐NH2([3H]pBC 254) Journal of Labelled Compounds and Radiopharmaceuticals. 31: 459-468. DOI: 10.1002/Jlcr.2580310606 |
0.523 |
|
| 1991 |
Bado A, Durieux C, Moizo L, Roques BP, Lewin MJM. Cholecystokinin-A receptor mediation of food intake in cats. American Journal of Physiology-Regulatory Integrative and Comparative Physiology. 260. PMID 2012242 DOI: 10.1152/Ajpregu.1991.260.4.R693 |
0.44 |
|
| 1991 |
Durieux C, Ruiz-Gayo M, Roques BP. In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264. European Journal of Pharmacology. 209: 185-193. PMID 1797561 DOI: 10.1016/0014-2999(91)90168-P |
0.542 |
|
| 1990 |
Dauge V, Bohme GA, Crawley JN, Durieux C, Stutzmann JM, Feger J, Blanchard JC, Roques BP. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264. Synapse (New York, N.Y.). 6: 73-80. PMID 2399491 DOI: 10.1002/Syn.890060109 |
0.47 |
|
| 1990 |
Gonzalez-Muniz R, Bergeron F, Marseigne I, Durieux C, Roques BP. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists. Journal of Medicinal Chemistry. 33: 3199-3204. PMID 1701834 DOI: 10.1021/Jm00174A016 |
0.479 |
|
| 1990 |
Ruiz-Gayo M, Delay-Goyet P, Durieux C, Corringer P, Baamonde A, Gacel G, Roques BP. Investigation of opioid and cholecystokinin central receptors after peripheral injection of selective and enzyme-resistant peptides Journal of Controlled Release. 13: 147-155. DOI: 10.1016/0168-3659(90)90006-F |
0.487 |
|
| 1989 |
Böhme GA, Durieux C, Stutzmann JM, Charpentier B, Roques BP, Blanchard JC. Electrophysiological studies with new CCK analogs: correlation with binding affinity on B-type receptors. Peptides. 10: 407-14. PMID 2755879 DOI: 10.1016/0196-9781(89)90051-X |
0.516 |
|
| 1989 |
Roy P, Charpentier B, Durieux C, Dor A, Roques BP. Conformational behavior of cyclic CCK‐related peptides determined by 400‐MHz 1H‐nmr: Relationships with affinity and selectivity for brain receptors Biopolymers. 28: 69-79. PMID 2720122 DOI: 10.1002/Bip.360280110 |
0.489 |
|
| 1989 |
Durieux C, Corringer P, Bergeron F, Roques BP. [3H]pBC 264, first highly potent and very selective radioligand for CCK-B receptors. European Journal of Pharmacology. 168: 269-270. PMID 2606153 DOI: 10.1016/0014-2999(89)90577-3 |
0.496 |
|
| 1989 |
Marseigne I, Roy A, Dor P, Durieux C, Pélaprat D, Reibaud M, Blanchard JC, Roques BP. Full agonists of CCK8 containing a nonhydrolyzable sulfated tyrosine residue Journal of Medicinal Chemistry. 32: 445-449. PMID 2464062 DOI: 10.1021/Jm00122A026 |
0.438 |
|
| 1988 |
Durieux C, Pham H, Charpentier B, Roques BP. Discrimination between CCK receptors of guinea-pig and rat brain by cyclic CCK8 analogues Biochemical and Biophysical Research Communications. 154: 1301-1307. PMID 3408499 DOI: 10.1016/0006-291X(88)90281-1 |
0.463 |
|
| 1988 |
Durieux C, Pélaprat D, Charpentier B, Morgat J, Roques BP. Characterization of [3H] CCK4 binding sites in mouse and rat brain. Neuropeptides. 12: 141-148. PMID 3241627 DOI: 10.1016/0143-4179(88)90045-5 |
0.455 |
|
| 1988 |
Charpentier B, Durieux C, Pelaprat D, Dor A, Reibaud M, Blanchard JC, Roques BP. Enzyme-resistant CCK analogs with high affinities for central receptors Peptides. 9: 835-841. PMID 3226959 DOI: 10.1016/0196-9781(88)90130-1 |
0.49 |
|
| 1988 |
Charpentier B, Pelaprat D, Durieux C, Dor A, Reibaud M, Blanchard JC, Roques BP. Cyclic cholecystokinin analogues with high selectivity for central receptors Proceedings of the National Academy of Sciences of the United States of America. 85: 1968-1972. PMID 3162318 DOI: 10.1073/Pnas.85.6.1968 |
0.488 |
|
| 1987 |
Charpentier B, Durieux C, Menant I, Roques BP. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties. Journal of Medicinal Chemistry. 30: 962-968. PMID 2438407 DOI: 10.1021/Jm00389A002 |
0.492 |
|
| 1986 |
Fournie-Zaluski MC, Belleney J, Lux B, Durieux C, Gerard D, Gacel G, Maigret B, Roques BP. Conformational analysis of cholecystokinin CCK26-33 and related fragments by 1H NMR spectroscopy, fluorescence-transfer measurements, and calculations. Biochemistry. 25: 3778-3787. PMID 3741836 DOI: 10.1021/Bi00361A008 |
0.368 |
|
| 1986 |
Durieux C, Charpentier B, Pelaprat D, Roques BP. Investigation on the metabolism of CCK8 analogues by rat brain slices Neuropeptides. 7: 1-9. PMID 3456492 DOI: 10.1016/0143-4179(86)90072-7 |
0.405 |
|
| 1986 |
Durieux C, Coppey M, Zajac J, Roques BP. Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex Biochemical and Biophysical Research Communications. 137: 1167-1173. PMID 3015138 DOI: 10.1016/0006-291X(86)90348-7 |
0.463 |
|
| 1985 |
Fournie-Zaluski MC, Durieux C, Lux B, Belleney J, Pham P, Gerard D, Roques BP. Conformational analysis of cholecystokinin fragments CCK4, CCK5, and CCK6 by 1H-NMR spectroscopy and fluorescence-transfer measurements. Biopolymers. 24: 1663-1681. PMID 4052579 DOI: 10.1002/Bip.360240903 |
0.385 |
|
| 1985 |
Durieux C, Charpentier B, Fellion E, Gacel G, Pelaprat D, Roques BP. Multiple cleavage sites of cholecystokinin heptapeptide by "enkephalinase". Peptides. 6: 495-501. PMID 3906590 DOI: 10.1016/0196-9781(85)90116-0 |
0.409 |
|
| 1985 |
Pélaprat D, Zajac J, Gacel G, Durieux C, Morgat J, Sasaki A, Roques BP. [3H] BOC [NLE28,31]CCK27−33, a new highly labelle ligand for CCK receptors: Binding on brain and on pancreas Life Sciences. 37: 2483-2490. PMID 3001463 DOI: 10.1016/0024-3205(85)90605-8 |
0.385 |
|
| 1985 |
Roques BP, Durieux C, Gacel G, Pélaprat D, Ruiz-Gayo M, Belleney J, Fellion E, Zajac JM, Fournié-Zaluski M, Daugé V, Menant I, Rossignol P, Lux B, Gérard D, Bécué D, et al. Studies on the Conformation, Enzymatic Degradation, Pharmacological Potency, and Binding Properties in Brain Tissue of Cholecystokinin‐8 and New Related Peptidesa Annals of the New York Academy of Sciences. 448: 61-75. PMID 2992350 DOI: 10.1111/J.1749-6632.1985.Tb29907.X |
0.35 |
|
| 1983 |
Durieux C, Belleney J, Lallemand J, Roques BP, Fournie-Zaluski M. 1H NMR conformational study of sulfated and non-sulfated cholecystokinin fragment CCK27-33: influence of the sulfate group on the peptide folding. Biochemical and Biophysical Research Communications. 114: 705-712. PMID 6882451 DOI: 10.1016/0006-291X(83)90838-0 |
0.42 |
|
| Show low-probability matches. |